Ziqiang Pang

Suggest Changes
Learn More
PURPOSE In this randomized phase II study, we evaluated the efficacy of semustine added to CEOP regimen as induction chemotherapy in patients with stage I(E)/II(E) extranodal NK/T-cell lymphoma,(More)
  • 1